- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Plymouth Meeting Today
By the People, for the People
INOVIO to Report Q4 and Full Year 2025 Results on March 12
Biotech firm to host conference call and webcast to discuss financial results and provide business update.
Published on Mar. 5, 2026
Got story updates? Submit your updates here. ›
INOVIO, a biotechnology company focused on developing DNA medicines, announced that it will release its fourth quarter and full year 2025 financial results after the market close on March 12, 2026. The company will then host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.
Why it matters
As a publicly traded biotech firm, INOVIO's quarterly and annual financial performance is closely watched by investors and analysts to gauge the company's progress in developing its pipeline of DNA-based treatments and vaccines. The upcoming earnings report and call will provide insight into INOVIO's financial health and business outlook.
The details
INOVIO specializes in developing DNA medicines to treat and protect against HPV-related diseases, cancers, and infectious diseases. The company's technology focuses on optimizing the design and delivery of DNA-based treatments that teach the body to manufacture its own disease-fighting tools.
- INOVIO will release its Q4 and full year 2025 financial results after the market close on March 12, 2026.
- The company will host a live conference call and webcast at 4:30 p.m. ET on March 12, 2026 to discuss the results.
The players
INOVIO
A biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases.
What’s next
Investors and analysts will be closely watching INOVIO's upcoming earnings report and conference call for updates on the company's financial performance and pipeline progress.
The takeaway
As a leader in DNA-based medicines, INOVIO's upcoming earnings report will provide important insights into the company's ability to advance its innovative treatment approaches and navigate the competitive biotech landscape.
